Real-world Evidence for Improvements in Inflammation and Anemia Biomarkers After the Initiation of GLP-1RA in Patients Receiving Hemodialysis
Kidney Medicine
Abstract
Rationale & objective Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used for diabetes and obesity but have not been studied in patients with kidney failure with replacement therapy receiving hemodialysis in prospective trials.
The paper
Renal Research Institute · Fresenius Medical Care (United States)
Kidney Medicine · 17 Jul 2026 · CC BY